Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
Del Mauro JS, Prince PD, Allo MA, Santander Plantamura Y, Morettón MA, González GE, Bertera FM, Carranza A, Gorzalczany SB, Chiappetta DA, Morales C, Gelpi RJ, Taira CA, Polizio AH, Donato M, Höcht C. Del Mauro JS, et al. Among authors: carranza a. J Hypertens. 2020 Mar;38(3):536-545. doi: 10.1097/HJH.0000000000002284. J Hypertens. 2020. PMID: 32028517
Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.
Del Mauro JS, Prince PD, Donato M, Fernandez Machulsky N, Morettón MA, González GE, Bertera FM, Carranza A, Gorzalczany SB, Chiappetta DA, Berg G, Morales C, Gelpi RJ, Taira CA, Höcht C. Del Mauro JS, et al. Among authors: carranza a. J Am Soc Hypertens. 2017 Apr;11(4):227-240. doi: 10.1016/j.jash.2017.02.007. Epub 2017 Mar 2. J Am Soc Hypertens. 2017. PMID: 28595719
Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.
Del Mauro JS, Prince PD, Santander Plantamura Y, Allo MA, Parola L, Fernandez Machulsky N, Morettón MA, Bin EP, González GE, Bertera FM, Carranza A, Berg G, Taira CA, Donato M, Chiappetta DA, Polizio AH, Höcht C. Del Mauro JS, et al. Among authors: carranza a. Hypertens Res. 2021 Jul;44(7):791-802. doi: 10.1038/s41440-021-00630-4. Epub 2021 Feb 22. Hypertens Res. 2021. PMID: 33612826
New and developing pharmacotherapies for hypertension.
Höcht C, Allo MA, Polizio AH, Morettón MA, Carranza A, Chiappetta DA, Choi MR. Höcht C, et al. Among authors: carranza a. Expert Rev Cardiovasc Ther. 2022 Aug;20(8):647-666. doi: 10.1080/14779072.2022.2105204. Epub 2022 Aug 3. Expert Rev Cardiovasc Ther. 2022. PMID: 35880547 Review.
122 results